Monday Dec 16
Applied Clinical Trials
Personalized Vaccine for Most Lethal Type of Brain Tumor Shows Promise
Analysis of phase 2 trial shows potential increase in survival for glioblastoma patients who received vaccine compared to standard of care; Study results support randomized NCI sponsored trial /PRNewswire-USNewswire/ -- Patients with recurrent glioblastoma multiforme treated with an experimental vaccine made from the patient's own resected tumor ... (more)
UTHealth's Arthur Day, M.D., honored by neurosurgical association
Arthur L. Day, M.D., professor of neurosurgery at The University of Texas Health Science Center at Houston and a neurosurgeon at the Mischer Neuroscience Institute at Memorial Hermann-Texas Medical Center, has received one of the top honors awarded by the Congress of Neurological Surgeons.
If All You Want for Christmas Is Relief From Back Pain, There Is Hope for You
Between 75 and 85 percent of all Americans suffer from back pain in their lifetimes, according to the American Institute of Neurological Surgeons.
Medical News Today
Breakthrough technologies and devices revealed at Congress of Neurological Surgeons Annual Meeting
The Congress of Neurological Surgeons hosted a groundbreaking Innovation and Technology Symposium at its recent Annual Meeting in San Francisco.
New Guidelines Rule Out Same-Day Return to Play for Athletes with Concussion
Any athlete with concussion symptoms should not be allowed to return to play on the same day, according to the latest consensus statement on sports-related concussion.
Breakthrough Technologies and Devices Revealed At Congress of Neurological Surgeons Annual Meeting
Schaumburg, IL, Dec. 4, 2013 - The Congress of Neurological Surgeons hosted a groundbreaking Innovation and Technology Symposium at its recent Annual Meeting in San Francisco.